The Impact of Positive Mental Training in Multiple Sclerosis
The Efficacy of Positive Mental Training in Patients With Multiple Sclerosis Experiencing Psychological Distress: A Pilot Randomised Controlled Trial
What it found
We found no results in the registry or in papers.
This trial finished 9 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Positive Mental Training
Placebo
- treatment as usual
What it measured
Main measures
Hospital Anxiety and Depression Scale (HADS)
Change from baseline after 12 weeks
Mood and sleepShort Warwick-Edinburgh Mental Well-being Scale (SWEMWBS)
Change from baseline after 12 weeks
Other measures (1)
Assessment of health-related quality of life - EuroQol health related quality of life - 5 dimensions - 5 levels (EuroQol-5D-5L)
Change from baseline after 12 weeks
Quality of life (reported by participants)
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Have confirmed diagnosis of Multiple Sclerosis
Exclusion criteria
* Lack capacity to provide informed consent * Judged by the treating clinician to have cognitive deficits of such severity to preclude engagement with the treatment * Felt by the treating clinician to be unsuitable to participate on other clinical grounds (e.g. significant receptive aphasia) will be excluded. * Do not speak English (they would be unable to independently make use of the intervention)
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Depression and anxiety are common in MS and often go untreated. Even symptoms which do not meet the threshold for a psychiatric diagnosis can have a significant impact on quality of life. Positive Mental Training (PosMT) is a 12 week programme which aims to help people overcome the negative thinking and feelings that come with worry and low mood and become more positive, confident and resilient. To find out if Positive Mental Training is helpful in MS the investigators are running a randomised controlled trial. The initial study is a pilot tiral, the primary function being examination of the feasibility and acceptability of this treatment in MS. Though sample size is small and consequently it may not be powered to detect a significant change in symptoms in association with the treatment, this will also be examined.
Loading reviews and guidelines…
History
Started
Jan 2016
Main results due
Jul 2017
Finished
Jul 2017